2005Journal of Practical Diagnosis and TherapyRequires access

Comparative study on propafenone and sotalol in paroxysmal rapid atrial fibrillation in non-rheumatic patient

Dao-Qi Zhou

Open publisher page 0 citations

Abstract

Objective To evaluate effects of propafenone and sotalol in paroxysmal rapid fibrillation in non-rheumatic patients. Methods Sixty patients with rapid atrial fibrillation between 0. 5 and 72 hours were randomly divided into two groups, treated with intravenous propafenone 70-210 mg and sotalol 1. 5 mg/kg respectively. Rhythms and heart rate were monitered. Results The effective rate of cardioversion for rapid atrial fibrillation was significantly highter in propafenone group (78. 1%)than in sotalol group (39. 3%)(P0. 05). The heart rate in the patients without cardioversion was decreased more in sotalol group(36%) than that in propafenone group (5. 2%)(P0. 05). While the mean time responding to the bolus was (46. 5 ± 38. 2) and (23. 9 ± 11. 5) minutes. Conclusion Propafenone is more effective than sotalol in reverting rapid atrial fibrillation. However,sotalol is more effective than propafenone in controlling rapid atrial fibrillation.

About this research paper

What this paper is about

Objective To evaluate effects of propafenone and sotalol in paroxysmal rapid fibrillation in non-rheumatic patients. Methods Sixty patients with rapid atrial fibrillation between 0. 5 and 72 hours were randomly divided into two groups, treated with intravenous propafenone 70-210 mg and sotalol 1. 5 mg/kg respectively. Rhythms and heart rate were monitered. Results The effective rate of cardioversion for rapid atrial fibrillation was significantly highter in propafenone group (78. 1%)than in sotalol group (39. 3%)(P0. 05). The heart rate in the patients without cardioversion was decreased more in sotalol group(36%) than that in propafenone group (5. 2%)(P0. 05). While the mean time responding to the bolus was (46. 5 ± 38. 2) and (23. 9 ± 11. 5) minutes. Conclusion Propafenone is more effective than sotalol in reverting rapid atrial fibrillation. However,sotalol is more effective than propafenone in controlling rapid atrial fibrillation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate effects of propafenone and sotalol in paroxysmal rapid fibrillation in non-rheumatic patients. Methods Sixty patients with rapid atrial fibrillation between 0. 5 and 72 hours were randomly divided into two groups, treated with intravenous propafenone 70-210 mg and sotalol 1. 5 mg/kg respectively. Rhythms and heart rate were monitered. Results The effective rate of cardioversion for rapid atrial fibrillation was significantly highter in propafenone group (78. 1%)than in sotalol group (39. 3%)(P0. 05). The heart rate in the patients without cardioversion was decreased more in sotalol group(36%) than that in propafenone group (5. 2%)(P0. 05). While the mean time responding to the bolus was (46. 5 ± 38. 2) and (23. 9 ± 11. 5) minutes. Conclusion Propafenone is more effective than sotalol in reverting rapid atrial fibrillation. However,sotalol is more effective than propafenone in controlling rapid atrial fibrillation.

Key concepts: Propafenone, Sotalol, Medicine, Atrial fibrillation, Cardiology, Cardioversion, Internal medicine, Bolus (digestion)

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparative study on propafenone and sotalol in paroxysmal rapid atrial fibrillation in non-rheumatic patient — Research Paper | ScholarLens